Ancilia Biosciences Inc.

New York, NY Ancilia Biosciences, Inc.

UEI
LYP2JAHDAA77
CAGE
8CVJ9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
3960 Broadway, New York, NY 10032, USA
Website
anciliabio.com
Founded
2019
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Ancilia Biosciences Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Enhancing e. Coli nissle colonization with crispr-CAS immunity - project summary inflammatory bowel disease (IBD)… Grant · R41DK141344 National Institute of Diabetes and Digestive and Kidney Diseases $548,802
Sttr phase i: phage-resistant bacterial therapeutics Grant · 2126989 National Science Foundation $255,717

Quick answers

What is Ancilia Biosciences Inc.'s UEI?

Ancilia Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is LYP2JAHDAA77.

What is Ancilia Biosciences Inc.'s CAGE code?

Ancilia Biosciences Inc.'s CAGE code is 8CVJ9.

What is Ancilia Biosciences Inc.'s primary NAICS code?

Ancilia Biosciences Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Ancilia Biosciences Inc. located?

Ancilia Biosciences Inc.'s physical address in SAM.gov is 3960 Broadway, New York, NY 10032, USA.

Is Ancilia Biosciences Inc. registered in SAM.gov?

Yes. Ancilia Biosciences Inc.'s SAM.gov registration is active through July 27, 2027.

What is Ancilia Biosciences Inc.'s most recent federal award?

Ancilia Biosciences Inc.'s most recent federal grant award is Enhancing e. Coli nissle colonization with crispr-CAS immunity - project summary inflammatory bowel disease (IBD)… (R41DK141344), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 19, 2024.

On GovTribe

See Ancilia Biosciences Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login